Abstract: Among other things, information is obtained by computer about Internet-related assets of organizations. The information is used to identify relationships between the organizations with respect to the assets. The information about the identified relationships is made available for display or analysis or both.

Abstract: Among other things, information is acquired and stored that is indicative of security risks associated with security subjects and with entities to which the security subjects belong. The stored information is analyzed by computer to derive security indicators for the entities. With respect to entities selected by the users, security information is presented by computer to users. The security information includes security indicators for the entities and security information for security subjects. The security information for security subjects includes annotations provided by users. The annotations are managed by computer based on communications from the users.

Abstract: Among other things, traces are received of activities of an online user who is associated with an entity. By analysis of the traces a security state of the entity is inferred. Also, a map is generated between (a) technical assets that contribute to security characteristics of respective entities and (b) the identities of the entities that are associated with the respective technical assets. At least part of the generating of the map is done automatically. A user can be engaged to assist in the generating of the map by presenting to the user through a user interface (a) data about the technical assets of entities and (b) an interactive tool for associating the technical assets with the identities of the entities.

Abstract: Among other things, traces are received of activities of an online user who is associated with an entity. By analysis of the traces a security state of the entity is inferred. Also, a map is generated between (a) technical assets that contribute to security characteristics of respective entities and (b) the identities of the entities that are associated with the respective technical assets. At least part of the generating of the map is done automatically. A user can be engaged to assist in the generating of the map by presenting to the user through a user interface (a) data about the technical assets of entities and (b) an interactive tool for associating the technical assets with the identities of the entities.

Abstract: A method and system for creating a composite security rating from security characterization data of a third party computer system. The security characterization data is derived from externally observable characteristics of the third party computer system. Advantageously, the composite security score has a relatively high likelihood of corresponding to an internal audit score despite use of externally observable security characteristics. Also, the method and system may include use of multiple security characterizations all solely derived from externally observable characteristics of the third party computer system.

Abstract: Among other things, traces are received of activities of an online user who is associated with an entity. By analysis of the traces a security state of the entity is inferred. Also, a map is generated between (a) technical assets that contribute to security characteristics of respective entities and (b) the identities of the entities that are associated with the respective technical assets. At least part of the generating of the map is done automatically. A user can be engaged to assist in the generating of the map by presenting to the user through a user interface (a) data about the technical assets of entities and (b) an interactive tool for associating the technical assets with the identities of the entities.

Abstract: Among other things, traces are received of activities of an online user who is associated with an entity. By analysis of the traces a security state of the entity is inferred. Also, a map is generated between (a) technical assets that contribute to security characteristics of respective entities and (b) the identities of the entities that are associated with the respective technical assets. At least part of the generating of the map is done automatically. A user can be engaged to assist in the generating of the map by presenting to the user through a user interface (a) data about the technical assets of entities and (b) an interactive tool for associating the technical assets with the identities of the entities.

Abstract: This invention relates to novel heteroaryl substituted pyrazole compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for treating hyper-proliferative and/or angiogenesis disorders, as a sole agent or in combination with other active ingredients or therapeutic measures.

Abstract: A carrier for transporting a child by a transporting individual The carrier includes a torso support part configured for supporting at least part of the torso of the child if the child is seated in the carrier, a seat support part coupled to the torso support part and configured for supporting the posterior of the child, and a hip belt coupled to the seat support part and configured for securing about the hips of the transporting individual. The seat support part is configured for enabling one or both upper legs of the child to hang substantially unsupported and in at least one alternative configuration at least one upper-leg-support part is coupled to the seat support part and to the hip belt and is configured for supporting at least part of one or both upper legs of the child.

Abstract: A compound of Formula (I): salts thereof, prodrugs thereof, metabolites thereof, pharmaceutical compositions containing such a compound, and use of such compound and compositions to treat diseases mediated by raf, VEGFR, PDGFR, p38 and flt-3.

Abstract: A carrier for transporting a child by a transporting individual The carrier includes a torso support part configured for supporting at least part of the torso of the child if the child is seated in the carrier, a seat support part coupled to the torso support part and configured for supporting the posterior of the child, and a hip belt coupled to the seat support part and configured for securing about the hips of the transporting individual. The seat support part is configured for enabling one or both upper legs of the child to hang substantially unsupported and in at least one alternative configuration at least one upper-leg-support part is coupled to the seat support part and to the hip belt and is configured for supporting at least part of one or both upper legs of the child.

Abstract: Disclosed are compounds and derivatives thereof, their synthesis, and their use as Rho-kinase inhibitors. These compounds are useful for inhibiting tumor growth, treating erectile dysfunction, and treating other indications mediated by Rho-kinase, e.g., coronary heart disease.

Abstract: A carrier for transporting a child by a transporting individual. The carrier includes a torso support part configured for supporting the torso of the child, a seat support part coupled to the torso support part, and at least one strap coupled to the torso support part and/or to the seat support part and with the torso support part and the seat support part configured to encircle at least part of the torso of the transporting individual. The seat support part is configured for supporting the posterior of the child in a sitting position in a first configuration, and the seat support part is configured for supporting the posterior of the child in a hanging position in a second configuration.

Abstract: Disclosed are compounds and derivatives thereof, their synthesis, and their use as Rho-kinase inhibitors. These compounds are useful for inhibiting tumor growth, treating erectile dysfunction, and treating other indications mediated by Rho-kinase, e.g., coronary heart disease.

Abstract: This invention relates to novel diaryl ureas, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for treating hyper-proliferative and angiogenesis disorders, as a sole agent or in combination with cytotoxic therapies.

Abstract: This invention relates to novel diaryl ureas, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for treating hyper-proliferative and angiogenesis disorders, as a sole agent or in combination with cytotoxic therapies.

Abstract: Disclosed is a method, a computer program product and a system for processing documents that contain chemical names. The system has a unit to partition document text and to assign semantic meaning to words; a unit to recognize any substructures present in the chemical name fragments; and a unit to determine structural connectivity information of the chemical name fragments and recognized substructures and to store the determined structural connectivity information in a searchable index. The system further includes a unit to search a text index using at least one of a fragment name and a substructure name and to search the structure index by at least one of fragment connectivity and substructure connectivity. At an intersection of the search results from the structure index and the text index, the system operates to identify at least one document that contains a reference to a corresponding chemical compound.

Abstract: This invention relates to novel heteroaryl substituted pyrazole compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for treating hyper-proliferative and/or angiogenesis disorders, as a sole agent or in combination with other active ingredients or therapeutic measures.

Abstract: Disclosed are compounds and derivatives thereof, their synthesis, and their use as Rho-kinase inhibitors. These compounds of the present invention are useful for inhibiting tumor growth, treating erectile dysfunction, and treating other indications mediated by Rho-kinase, e.g., coronary heart disease.

Abstract: A process for the preparation of various quinazoline compounds which are useful as Rho-Kinase inhibitors, and thus having utility in the treatment of hypertension and other indications.